3D bio

3D Bio is a clinical-stage biotechnology company founded in 2014, headquartered in New York, USA. It focuses on regenerative medicine and device development to support the implantation of living tissues and organs. Utilizing its patented 3D bioprinting technology, 3D Bio provides structurally and functionally complete, safe living tissue implants designed on-demand for patients. To date, the company has successfully completed the world's first clinical human trial of a 3D-printed ear.